Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Mar 23 2017

Full Issue

Ex-Compounding Pharmacy Exec Acquitted Of Murder Allegations In Meningitis Outbreak

Barry J. Cadden, the former co-owner and head pharmacist at the New England Compounding Center, was found guilty by jurors of fraud and racketeering. Fungus-tainted drugs from the facility killed 64 people and sickened hundreds more across the country.

The former co-owner and head pharmacist at a Framingham company that shipped tainted drugs across the country, causing more than 60 deaths and hundreds of illnesses, was convicted of fraud and racketeering Wednesday, though a federal jury refused to brand him a murderer. Barry J. Cadden, who jurors found had run New England Compounding Center like a criminal enterprise, could serve several years in prison. But the jury’s verdict spared him from a life sentence in one of the worst pharmaceutical scandals in US history. (Valencia and Lazar, 3/22)

The former head of a Massachusetts pharmacy was acquitted Wednesday of murder allegations but convicted of racketeering and other crimes in a meningitis outbreak that was traced to fungus-contaminated drugs and killed 64 people across the country. Prosecutors said Barry Cadden, 50, ran the business in an ‘‘extraordinarily dangerous’’ way by disregarding unsanitary conditions to boost production and make more money. (Lavoie, 3/22)

The former co-owner of the New England Compounding Center, the pharmaceutical company at the center of a meningitis outbreak in 2012, has been found not guilty on the most serious charges in that trial but convicted of other charges. Barry Cadden was charged with murder, racketeering and fraud in relation to the 2012 nationwide fungal meningitis outbreak that killed 64 people and sickened nearly 700. A Boston federal jury today found Cadden not guilty of second degree murder, and guilty on more than 50 other lesser counts. (Chakrabart, Sundt and McNerney, 3/22)

The head of a New England compounding pharmacy that produced tainted drugs was found not guilty of second degree murder but guilty on other charges. At least 25 patients died, and many others got sick. (Emanuel, 3/22)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ